AQST - Aquestive Therapeutics - Stock Forecast

Healthcare - Sector
Coverage Stock analysts Price Targets & Ratings Chart Insider Trading

AQST is currently covered by 4 analysts with an average price target of $8.33. This is a potential upside of $4.5 (117.49%) from yesterday's end of day stock price of $3.83.

Aquestive Therapeutics's activity chart (see below) currently has 135 price targets and 109 ratings on display. The stock rating distribution of AQST is 100% BUY.

Stock Analyst Price Targets - Review

Analysts average stock forecasts to be materialized ratio is 20.56% with an average time for these price targets to be met of 132.82 days.

Highest price target for AQST is $10, Lowest price target is $6, average price target is $8.33.

Most recent stock forecast was given by RAGHURAM SELVARAJU from HC WAINWRIGHT on 24-Aug-2026. First documented stock forecast 20-Aug-2018.

Best performing analysts who are covering AQST - Aquestive Therapeutics:

Thomas Flaten Gary Nachman Raghuram Selvaraju Andreas Argyrides

Currently out of the existing stock ratings of AQST, 7 are a BUY (100%).

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date of last PT

Price targets met ratio

Average potential upside

Average Days to Hit Target

Performance score

Buy Since 22-Apr-2019

$10

$6.22 (164.55%)

$10

1 months 26 days ago
(24-Aug-2026)

9/33 (27.27%)

$5.2 (108.33%)

323

Buy Since 20-Aug-2018

$10

$6.22 (164.55%)

$10

5 months 5 days ago
(15-May-2026)

0/17 (0%)

$5.83 (139.81%)

Buy Since 08-Sep-2025

$8

$3.61 (82.23%)

$8

5 months 26 days ago
(24-Apr-2026)

1/3 (33.33%)

$3.92 (96.08%)

135

Buy Since 03-Jan-2019

$6

$2.22 (58.73%)

$8

8 months 17 days ago
(03-Feb-2026)

3/10 (30%)

$1.9 (46.34%)

592

Buy Since 11-Apr-2024

$8

$4.22 (111.64%)

$8

11 months 8 days ago
(12-Nov-2025)

0/3 (0%)

$2.42 (43.37%)

Show more analysts

Please expand the browser size to see the chart

What is AQST (Aquestive Therapeutics) average time for price targets to be met?

On average it took 133 days for the stock forecasts to be reached, with an average price target met ratio of 20.56%.

Which analyst most recently updated their price target on AQST (Aquestive Therapeutics)?

Raghuram Selvaraju

Which analyst has the most public recommendations on AQST (Aquestive Therapeutics)?

Raghuram Selvaraju has 64 price targets and 43 ratings on AQST

Which analyst is the currently most bullish on AQST (Aquestive Therapeutics)?

Kristen Kluska with the highest potential upside of $11.22

Which analyst is the currently most reserved on AQST (Aquestive Therapeutics)?

Thomas Flaten with the lowest potential downside of $2.22
✖

To continue looking at which analysts cover the stock please register to the basic or advanced membership

To continue looking at analysts data please register to the advanced membership

What is AnaChart?